LBA36 Safety and antitumor activity of dostarlimab in patients (pts) with advanced or recurrent DNA mismatch repair deficient (dMMR) or proficient (MMRp) endometrial cancer (EC): Results from GARNET

Ana Oaknin, Lucy Gilbert, Anna V. Tinker, Renaud Sabatier, Valentina Boni, David M. O’Malley, Sharad Ghamande, Linda Duska, Prafull Ghatage, Wei Guo, E. Im, Bhavana Pothuri